Ibogaine, a natural alkaloid from the Tabernanthe iboga plant, has been used for centuries in West African traditions and is known for anti-addictive effects. In human red blood cells treated in the lab, ibogaine increased ATP levels in blood plasma without altering cell membrane flexibility or uric acid. It boosted activity of the antioxidant enzyme SOD1 at both 10 and 20 µM doses, and at the higher dose also increased glutathione reductase activity. Ibogaine protected SOD1 from damage by hydrogen peroxide. These results suggest ibogaine supports energy metabolism and acts as a pro-antioxidant by enhancing antioxidant enzyme activity, potentially helping cells adapt to oxidative stress.
Ibogaine, known for its anti-addictive effects, alters energy metabolism in a way that is not species- or tissue-specific. In yeast (Saccharomyces cerevisiae) grown with 1 mg/l ibogaine for 5 hours, enzymes involved in energy production—glyceraldehyde-3-phosphate dehydrogenase, phosphoglycerate kinase, enolase, and alcohol dehydrogenase—were induced. This induction compensates for a drop in ATP levels observed after ibogaine exposure. The effect occurs without involvement of receptors, which are absent in yeast, indicating a direct metabolic influence rather than receptor-mediated action.